Literature Lessons
A single center retrospective analysis compared 7,361 biological drug recipients with 74,910 matched patients. There was not an increased risk of COVID-19 infection or an increased risk of COVID-19-related mortality among the biologic drug recipient cohort. Prominent among the drugs received were adalimumab (28.4%), infliximab (15.6%), and etanercept (11.9%), as well as rituximab (15.6%) and […]
Addressing perceptions of risk with sunscreen use
Dr. Tasneem Mohammad discusses patient perceptions of risk related to several sunscreen controversies that can impede compliance thereby increasing the risk for skin cancer and pigmentary disorders. “As dermatologists, it’s really our duty to be able to know about all of these [sunscreen] controversies, know the evidence behind it, and be able to counsel not […]